PortfoliosLab logoPortfoliosLab logo
UTHR vs. CTLT
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

UTHR vs. CTLT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in United Therapeutics Corporation (UTHR) and Catalent, Inc. (CTLT). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

UTHR vs. CTLT - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
UTHR
United Therapeutics Corporation
21.70%38.09%60.46%-20.93%28.70%42.35%72.33%-19.12%-26.39%3.15%
CTLT
Catalent, Inc.
0.00%0.00%41.29%-0.18%-64.84%23.02%84.85%80.56%-24.10%52.37%

Fundamentals

Total Revenue (TTM)

UTHR:

$3.18B

CTLT:

$4.42B

Gross Profit (TTM)

UTHR:

$2.80B

CTLT:

$965.00M

EBITDA (TTM)

UTHR:

$1.82B

CTLT:

$399.00M

Returns By Period


UTHR

1D
0.79%
1M
17.68%
YTD
21.70%
6M
41.45%
1Y
92.36%
3Y*
38.34%
5Y*
25.25%
10Y*
18.04%

CTLT

1D
1M
YTD
6M
1Y
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

UTHR vs. CTLT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

UTHR
UTHR Risk / Return Rank: 9393
Overall Rank
UTHR Sharpe Ratio Rank: 8989
Sharpe Ratio Rank
UTHR Sortino Ratio Rank: 9494
Sortino Ratio Rank
UTHR Omega Ratio Rank: 9494
Omega Ratio Rank
UTHR Calmar Ratio Rank: 9595
Calmar Ratio Rank
UTHR Martin Ratio Rank: 9494
Martin Ratio Rank

CTLT
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

UTHR vs. CTLT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for United Therapeutics Corporation (UTHR) and Catalent, Inc. (CTLT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


UTHRCTLTDifference

Sharpe ratio

Return per unit of total volatility

1.84

Sortino ratio

Return per unit of downside risk

3.30

Omega ratio

Gain probability vs. loss probability

1.46

Calmar ratio

Return relative to maximum drawdown

5.70

Martin ratio

Return relative to average drawdown

14.49

UTHR vs. CTLT - Sharpe Ratio Comparison


Loading graphics...

Sharpe Ratios by Period


UTHRCTLTDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.84

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.72

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.51

Sharpe Ratio (All Time)

Calculated using the full available price history

0.39

Correlation

The correlation between UTHR and CTLT is 0.30, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

UTHR vs. CTLT - Dividend Comparison

Neither UTHR nor CTLT has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

UTHR vs. CTLT - Drawdown Comparison


Loading graphics...

Drawdown Indicators


UTHRCTLTDifference

Max Drawdown

Largest peak-to-trough decline

-93.18%

Max Drawdown (1Y)

Largest decline over 1 year

-16.35%

Max Drawdown (5Y)

Largest decline over 5 years

-33.00%

Max Drawdown (10Y)

Largest decline over 10 years

-55.56%

Current Drawdown

Current decline from peak

0.00%

Average Drawdown

Average peak-to-trough decline

-35.53%

Ulcer Index

Depth and duration of drawdowns from previous peaks

6.43%

Volatility

UTHR vs. CTLT - Volatility Comparison


Loading graphics...

Volatility by Period


UTHRCTLTDifference

Volatility (1M)

Calculated over the trailing 1-month period

17.05%

Volatility (6M)

Calculated over the trailing 6-month period

26.84%

Volatility (1Y)

Calculated over the trailing 1-year period

50.41%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

35.89%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

35.32%

Financials

UTHR vs. CTLT - Financials Comparison

This section allows you to compare key financial metrics between United Therapeutics Corporation and Catalent, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


400.00M600.00M800.00M1.00B1.20B1.40BAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
790.20M
1.02B
(UTHR) Total Revenue
(CTLT) Total Revenue
Values in USD except per share items